Company / Free Cash Flow per Share
Roivant Sciences Free Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.10
FY2025
5-year range
-$1.10 / -$0.86
FY2021-FY2025
Trend
-5.3%
vs FY2024
Sector context
#106 of 192
Health Care
What the data says
At $-1.10, Roivant Sciences's free cash flow per share ranks #106 of 192 in the Health Care sector. Free Cash Flow per Share has declined for 3 consecutive years, from $-0.86 in FY2022 to $-1.10 in FY2025.
Based on SEC 10-K filings.
-1.10 in FY2025.
Declined from $-1.01 to $-1.10 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#106 of 192 in Health CareTop 55% of 192This company -$1.10 Sector average $3.32
▼
-133.2% below sector average
Key checks
Key Insights
- Roivant Sciences's free cash flow per share has declined for 3 consecutive years.
- In FY2025, free cash flow per share decreased 5.3% year-over-year.
- Ranks #106 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.10 | -5.3% |
| FY2024 | -$1.05 | -3.7% |
| FY2023 | -$1.01 | -17.8% |
| FY2022 | -$0.86 | +17.5% |
| FY2021 | -$1.04 | -17.2% |
| FY2020 | -$0.89 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026